Health System Success in Delivering Bamlanivimab Within Post-acute and Long-Term Care Facilities

Post-acute and long-term care (PALTC) residents are disproportionately affected by coronavirus 2019 (COVID-19). We describe a health system approach that incorporated PALTC stakeholders to treat residents effectively and efficiently with monoclonal antibodies during the pandemic.